醫械創新資訊
參考資料：
[1] FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD. Retrieved June 15, 2020, from https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-game-based-digital-therapeutic-improve-attention-function-children-adhd?utm_campaign=061520_PR_FDA%20Permits%20Marketing%20of%20Digital%20Therapeutic%20for%20Children%20with%20ADHD&utm_medium=email&utm_source=Eloqua
[2] Kollins et al., (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digital Health, https://doi.org/10.1016/S2589-7500(20)30017-0[3] Akili Announces FDA Clearance of EndeavorRxTM for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game. Retrieved June 15, 2020, from https://www.businesswire.com/news/home/20200615005739/en
